Institutional investors purchased a net $8.9 million shares of NVO during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 9.01% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Major industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CHAUTAUQUA CAPITAL MANAGEMENT LL... Bought 60.5 Thousand shares of Novo Nordisk A/S
NAVELLIER & ASSOCIATES, INC. Bought 6.3 Thousand shares of Novo Nordisk A/S
DAVENPORT & CO. LLC Bought 5.8 Thousand shares of Novo Nordisk A/S